Clinical and epidemiological characteristics and impact of non-pharmacological measures on the evolution of the COVID-19 pandemic among residents of a highaltitude region of Peru
DOI:
https://doi.org/10.24265/horizmed.2023.v23n4.04Keywords:
mortality, COVID-19, public health, altitude, PeruAbstract
Objective: To describe the clinical and epidemiological characteristics and the impact of non-pharmacological measures (NFMs) on the evolution of the COVID-19 pandemic among residents of a high-altitude region of Peru.
Materials and methods: The study was conducted in the district of Lircay (3,278 m a.s.l.), province of Angaraes, department of Huancavelica, between March 31, 2020, and January 31, 2021 (lockdown period). The Information Technology Department at Hospital Lircay MINSA II-1 provided all COVID-19 patient records used during the aforementioned period of time. The clinical and epidemiological characteristics and the impact of NFMs were evaluated by determining the transmissibility of the virus using the effective reproduction number (Rt). Results: A total of 1,404 COVID-19 patients from the district of Lircay, who were treated at Hospital Lircay MINSA II-1, were studied. The median age was 33 years (IQR: 24.0–45.0); 10.7 % were older adults and 70 % reported no comorbidities at diagnosis. Out of all participants, 2.16 % had a moderate or severe condition, being more frequent in males (p < 0.001). Moreover, the significantly associated comorbidities were obesity (p < 0.001) and hypertension (p = 0.004). The average case fatality rate was 0.9 %; however, in moderate–severe cases, it reached 26.7 % (p < 0.001), and the elderly population was the most affected one. The lockdown, understood as an NFM, generated an Rt of 2.98 (95 % CI: 1.54–5.14) in July, and the end of the lockdown plus the economic recovery generated an Rt of 9.94 (95 % CI: 4.19–19.45) in December. After Christmas, focused lockdown was introduced and, 14 days later, an Rt reduction of up to 0.79 (95 % CI: 0.41–1.36) was observed. Conclusions: In this high-altitude region, the COVID-19 overall case fatality rate was low; this could be related to the characteristics of the population (young age and low prevalence of comorbidities). Lockdown apparently proved to be an effective measure for controlling SARS-CoV-2 transmissibility
Downloads
References
Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA 2020;323(13):1239-42.
Tan W, Zhao X, Ma X, Wang W, Niu P, Xu W, et al. A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases Wuhan, China 2019-2020. CCDCW. 2020;2(4):61-2.
World Health Organization. Naming the coronavirus disease (COVID-19) and the virus that causes it [Internet]. Geneva: WHO. [citado el 21 de mayo de 2023]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-thevirus-that-causes-it
Johns Hopkins University & Medicine. COVID-19 Map [Internet]. Johns Hopkins Coronavirus Resource Center. 2021 [citado el 21 de mayo de 2023]. Disponible en: https://coronavirus.jhu.edu/map.html
Instituto Nacional de Salud y Centro Nacional de Epidemiologia, Prevencion y Control de Enfermedades del Ministerio de Salud. COVID-19 en el Peru [Internet]. Lima: MINSA. 2021 [citado el 21 de mayo de 2023]. Disponible en: https://covid19.minsa.gob.pe/sala_situacional.asp
Torres-Roman JS, Kobiak IC, Valcarcel B, Diaz-Velez C, La Vecchia C. The reproductive number R0 of COVID-19 in Peru: An opportunity for effective changes. Travel Med Infect Dis. 2020;37:101689.
Hartley DM, Perencevich EN. Public Health Interventions for COVID-19: Emerging Evidence and Implications for an Evolving Public Health Crisis. JAMA. 2020;323(19):1908-9.
Yang R, Gui X, Xiong Y. Comparison of Clinical Characteristics of Patients with Asymptomatic vs Symptomatic Coronavirus Disease 2019 in Wuhan, China. JAMA Netw Open. 2020;3(5):e2010182.
Cheng HY, Jian SW, Liu DP, Ng TC, Huang WT, Lin HH, et al. Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset. JAMA Intern Med. 2020;180(9):1156-63.
Pan A, Liu L, Wang C, Guo H, Hao X, Wang Q, et al. Association of Public Health Interventions with the Epidemiology of the COVID-19 Outbreak in Wuhan, China. JAMA. 2020;323(19):1915-23.
Zapata R, Santos G, Estrada M, Tovar A, Atamain Y, Chacon K, et al. La dura travesia de los mas pobres: pandemia y desempleo expulsan a miles de migrantes [Internet]. Ojo Publico. 2020 [citado el 21 de mayo de 2023]. Disponible en: https://ojo-publico.com/1786/desplazados-por-la-pandemia-la-travesia-los-mas-pobres
Instituto Nacional de Estadistica e Informatica. Resultados Definitivos de los Censos Nacionales 2017 [Internet]. Lima: INEI. 2017 [citado el 21 de mayo de 2023]. Disponible en: https://censo2017.inei.gob.pe/resultados-definitivos-de-los-censos-nacionales-2017/
Ministerio de Salud. Resolucion Ministerial N.ï¿1/2 546-2011-MINSA [Internet]. Lima: MINSA; 2011 [citado el 21 de mayo de 2023] p. 148. Disponible en: https://www.gob.pe/institucion/minsa/normaslegales/243402-546-2011-minsa
Ministerio de Salud. Resolucion Ministerial N.ï¿1/2 183-2020-MINSA [Internet]. Lima: MINSA; 2020 [citado el 21 de mayo de 2023] p. 24. Disponible en: https://www.gob.pe/institucion/minsa/normaslegales/473230-183-2020-minsa
Cori A, Ferguson NM, Fraser C, Cauchemez S. A New Framework and Software to Estimate Time-Varying Reproduction Numbers During Epidemics. Am J Epidemiol. 2013;178(9):1505-12.
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020;382(18):170820.
Vera-Ponce VJ, Mendez-Aguilar P, Ichiro-Peralta C, Failoc-Rojas VE, Valladares-Garrido MJ. Factores asociados a seropositividad para SARS-CoV-2 en pacientes atendidos en un hospital de zona altoandina peruana. Rev Cuerpo Med HNAAA. 2021;14:8-12.
Diaz-Lazo A, Montalvo R, Lazarte E, Aquino E. Caracterizacion clinica y epidemiologica de los pacientes con COVID-19 en un hospital situado en la altura. Horiz Med. 2021;21(2).
Flores MG, Soto A, De la cruz JA. Distribucion regional de mortalidad por COVID-19 en Peru. Rev Fac Med Hum. 2021;21(2):326-34.
Ortiz-Prado E, Fernandez RP, Vasconez E, Simbana-Rivera K, CorreaSancho T, Lister A, et al. Analysis of Excess Mortality Data at Different Altitudes During the COVID-19 Outbreak in Ecuador. High Alt Med Biol. 2021;22(4):406-16.
Araujo M, Ossandon P, Abarca AM, Menjiba AM, Munoz AM. Pronostico de pacientes hospitalizados por COVID-19 en un centro terciario en Chile: estudio de cohorte. Medwave. 2020;20(10): e8066.
Sanhueza-Sanzana C, Oliveira IW, Freitas RL, Kendall C, Mendes A, Sansigolo LRF. Social inequalities associated with COVID-19 case fatality rate in Fortaleza, Ceara state, Brazil, 2020. Epidemiol Serv Saude (Online). 2021;30(3):e2020743.
Castro HM, Canale HL, Ferreyro BL, Prieto MA, Massimino BE, Funtowicz G, et al. Caracteristicas clinicas de la enfermedad por Coronavirus 2019 en un centro de Argentina. Cohorte retrospective. Medicina (Buenos Aires). 2020;80(Supl. VI):35-43.
Acosta G, Escobar G, Bernaola G, Alfaro J, Taype W, Marcos C, et al. Caracterizacion de pacientes con COVID-19 grave atendidos en un hospital de referencia nacional del Peru. Rev Peru Med Exp Salud Publica. 2020;37(2):253-8.
Yupari-Azabache I, Bardales-Aguirre L, Rodriguez-Azabache J, Barros-Sevillano JS, Rodriguez-Diaz A. Factores de riesgo de mortalidad por COVID-19 en pacientes hospitalizados: Un modelo de regresion logistica. Rev Fac Med Hum. 2021;21(1):19-27.
Byambasuren O, Cardona M, Bell K, Clark J, McLaws ML, Glasziou P. Estimating the extent of asymptomatic COVID-19 and its potential for community transmission: Systematic review and meta-analysis. J Assoc Med Microbiol Infect Dis Can. 2020;5(4):223-34.
White EM, Santostefano CM, Feifer RA, Kosar CM, Blackman C, Gravenstein S, et al. Asymptomatic and Presymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection Rates in a Multistate Sample of Skilled Nursing Facilities. JAMA Intern Med. 2020;180(12):1709-11.
Lee S, Kim T, Lee E, Lee C, Kim H, Rhee H, et al. Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea. JAMA Intern Med. 2020;180(11):1447-52.
Wiersinga WJ, Rhodes A, Cheng AC, Peacock SJ, Prescott HC. Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;324(8):782-93.
Noriega V, Pria MC, Corral A, Alvarez M, Bonet M. La infeccion asintomatica por el SARS-CoV-2: evidencias para un estudio poblacional en Cuba. Rev Cub Salud Publica. 2021;46(Supl Especial):1-16.
Diaz-Velez C, Failoc-Rojas VE, Valladares-Garrido MJ, Colchado J, Carrera-Acosta L, Becerra M, et al. SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020. PeerJ. 2021;9:e11210.
Ministerio de Salud. Resolucion Ministerial N.ï¿1/2 905-2020-MINSA[Internet]. Lima: MINSA; 2020 [citado el 21 de mayo de 2023] p. 29. Disponible en: https://www.gob.pe/institucion/minsa/normas-legales/1322786905-2020-minsa
Ministerio de Salud. Resolucion Ministerial N.o 972-2020-MINSA [Internet]. Lima: MINSA; 2020 [citado el 21 de mayo de 2023] p. 31. Disponible en: https://www.gob.pe/institucion/minsa/normaslegales/1366422-972-2020-minsa
Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM, et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science. 2020;368(6490):493-7.
Tian H, Liu Y, Li Y, Wu CH, Chen B, Kraemer MUG, et al. An investigation of transmission control measures during the first 50 days of the COVID-19 epidemic in China. Science. 2020;368(6491):638-42.
Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395-400.
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Luisser Dainner Saavedra Córdova , Alberto Alcibíades Salazar Granara
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
